Lilly and Novo Nordisk, the maker of Ozempic and Wegovy, have been under pressure to lower the cost of their hugely popular — but pricey — weight loss drugs. In July, President Joe Biden and Sen.
Paid Advertisement Millions of people throughout the world battle to stay at a healthy weight. With obesity rates rising and linked health conditions such as type 2 diabetes, cardiovascular ...